Evidence map›Paper›PMID 36835182›Full record

ArticleInternational journal of molecular sciences2023

A Proposed Methodology to Deal with the Impact of In Vitro Cellular Matrix on the Analytical Performances of a Targeted Metabolomic LC-HRMS Method.

Jérôme Guitton, Floriane Gavotto, Emeline Cros-Perrial, Lars Petter Jordheim, Christelle Machon

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jérôme GuittonBiochemistry and Toxicology Laboratory, Lyon Sud Hospital, University Hospital of Lyon, CEDEX, 69495 Pierre-Bénite, France.ORCID 0000-0001-6180-5708
Floriane GavottoBiochemistry and Toxicology Laboratory, Lyon Sud Hospital, University Hospital of Lyon, CEDEX, 69495 Pierre-Bénite, France.ORCID 0000-0001-9793-3680
Emeline Cros-PerrialInserm U1052, CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon, 69000 Lyon, France.
Lars Petter JordheimInserm U1052, CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon, 69000 Lyon, France.ORCID 0000-0003-3948-7090
Christelle MachonBiochemistry and Toxicology Laboratory, Lyon Sud Hospital, University Hospital of Lyon, CEDEX, 69495 Pierre-Bénite, France.ORCID 0000-0002-4494-8034
Université Claude Bernard Lyon 1 · FRUniversity of Luxembourg · LU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Performances of metabolomic methods have been widely studied on biological matrices such as serum, plasma, and urine; but much less on in vitro cell extracts. While the impact of cell culture and sample preparation on results are well-described, the specific effect of the in vitro cellular matrix on the analytical performance remains uncertain. The aim of the present work was to study the impact of this matrix on the analytical performance of an LC-HRMS metabolomic method. For this purpose, experiments were performed on total extracts from two cell lines (MDA-MB-231 and HepaRG) using different cell numbers. Matrix effects, carryover, linearity, and variability of the method were studied. Results showed that the performances of the method depend on the nature of the endogenous metabolite, the cell number, and the nature of the cell line. These three parameters should, therefore, be considered for the processing of experiments and the interpretation of results depending on whether the study focuses on a limited number of metabolites or aims to establish a metabolic signature.

Indexed as

MetabolomeMetabolomicsCell Culture TechniquesCell LinePlasmaanalytical performancescell extractshigh resolution mass spectrometryliquid chromatographymatrix effecttargeted metabolomic

Identifiers

PMID36835182
PMCPMC9965333
OpenAlexW4320731297

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.